Clinical Trial Update: Cytosponge Protocol IRB 11-006429 [NA]

View source ↗

Summary

Trial update for Cytosponge protocol IRB 11-006429 related to eosinophilic esophagitis; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Snippet

Sponsor: Mayo Clinic | Conditions: Eosinophilic Esophagitis | NA | Status: TERMINATED | Results posted: 2022-05-18